Trehu Elizabeth
Chief Medical Officer at Jounce Therapeutics, Inc.
- Sold, on record
- $570k
- Dollars the filings state
- Form 4 sales
- 10
- Latest Jan 10, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Jounce Therapeutics, Inc.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Jounce Therapeutics, Inc.Plan not statedJan 7, 2020 2020
Sold 2,624 shares at $7.78 ($20k)
Trehu Elizabeth, Chief Medical Officer
Sold 4.4% of holdings ($460k position)56,565 shares left0.6x usual sizeFiling
- 2 Form 4 sale Jounce Therapeutics, Inc.Plan not statedAug 17, 2020 +223 days
Sold 2,182 shares at $4.71 ($10k)
Trehu Elizabeth, Chief Medical Officer
Sold 2.8% of holdings ($371k position)76,633 shares leftFiling
- 3 Form 4 sale Jounce Therapeutics, Inc.Plan not statedJan 8, 2021 +144 days
Sold 5,298 shares at $6.89 ($36k)
Trehu Elizabeth, Chief Medical Officer
Sold 6.9% of holdings ($528k position)71,335 shares left2.3x usual sizeFiling
- 4 Form 4 sale Jounce Therapeutics, Inc.Plan not statedJan 20, 2021 +12 days
Sold 6,500 shares at $12.01 ($78k)
Trehu Elizabeth, Chief Medical Officer
Sold 8.4% of holdings ($935k position)71,335 shares left2.6x usual sizeFiling
- 5 Form 4 sale Jounce Therapeutics, Inc.UnusualMar 31, 2021 +70 days
Sold 13,500 shares at $10.09 ($136k)
Trehu Elizabeth, Chief Medical Officer
Sold 12.6% of holdings ($1.1M position)93,585 shares left5.1x usual sizeFiling
- 6 Form 4 sale Jounce Therapeutics, Inc.Plan not statedJan 10, 2022 +285 days
Sold 8,383 shares at $6.88 ($58k)
Trehu Elizabeth, Chief Medical Officer
Sold 9% of holdings ($644k position)85,202 shares left1.4x usual sizeFiling
- 7 Form 144 notice Jounce Therapeutics, Inc.NoticeJan 6, 2023 +361 days
Filed to sell 10,000 shares ($11k)
Trehu Elizabeth, Officer
10b5-1 plan1.3x usual sizeFiling
- 8 Form 4 sale Jounce Therapeutics, Inc.Plan not statedJan 10, 2023 +4 days
Sold 9,285 shares at $1.11 ($10k)
Trehu Elizabeth, Chief Medical Officer
Sold 8.2% of holdings ($125k position)103,417 shares left1.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2023 | Jan 11, 2023 | Jounce Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 9,285 | $10k | 8.2% | Plan not stated | SEC |
| Jan 6, 2023 | Jan 6, 2023 | Jounce Therapeutics, Inc. | Officer | Form 144 notice | 10,000 | $11k | Notice | SEC | |
| Jan 10, 2022 | Jan 11, 2022 | Jounce Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 8,383 | $58k | 9.0% | Plan not stated | SEC |
| Mar 31, 2021 | Mar 31, 2021 | Jounce Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 13,500 | $136k | 12.6% | Unusual | SEC |
| Jan 20, 2021 | Jan 22, 2021 | Jounce Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 6,500 | $78k | 8.4% | Plan not stated | SEC |
| Jan 8, 2021 | Jan 11, 2021 | Jounce Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 5,298 | $36k | 6.9% | Plan not stated | SEC |
| Aug 17, 2020 | Aug 18, 2020 | Jounce Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 2,182 | $10k | 2.8% | Plan not stated | SEC |
| Jan 7, 2020 | Jan 10, 2020 | Jounce Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 2,624 | $20k | 4.4% | Plan not stated | SEC |
| Aug 16, 2019 | Aug 16, 2019 | Jounce Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 2,336 | $9k | 3.8% | Plan not stated | SEC |
| Mar 8, 2018 | Mar 12, 2018 | Jounce Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 4,545 | $114k | 100.0% | Unusual | SEC |
| Mar 5, 2018 | Mar 7, 2018 | Jounce Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 4,545 | $98k | 100.0% | Unusual | SEC |